BRUKER CORPORATION Payments to Acquire Businesses, Gross
BRUKER CORPORATION (BRKR) reported Payments to Acquire Businesses, Gross of $38.00 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquireBusinessesGross · last filed 2026-08-05
- BRUKER CORPORATION payments to acquire businesses, gross for the quarter ending 2026-06-30 was $0.00.
- BRUKER CORPORATION payments to acquire businesses, gross for the quarter ending 2026-03-31 was $38.00M.
- BRUKER CORPORATION payments to acquire businesses, gross for the quarter ending 2025-12-31 was $3.90M, a 82.11% decline year-over-year.
- BRUKER CORPORATION payments to acquire businesses, gross for the quarter ending 2025-09-30 was $0.00, a 100.00% decline year-over-year.
- BRUKER CORPORATION payments to acquire businesses, gross for fiscal 2024 was $1.65B, a 579.64% increase from fiscal 2023.
- BRUKER CORPORATION payments to acquire businesses, gross for fiscal 2023 was $242.60M.
| Period end | Payments to Acquire Businesses, Gross 3 month | Payments to Acquire Businesses, Gross 6 month | Payments to Acquire Businesses, Gross 9 month | Payments to Acquire Businesses, Gross 12 month |
|---|---|---|---|---|
| 2026-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | $38.00M 10-Q · filed 2026-08-05 | $41.90M derived: sum of 3 quarters · filed 2026-08-05 | $41.90M derived: sum of 4 quarters · filed 2026-08-05 |
| 2026-03-31 | $38.00M 10-Q · filed 2026-05-07 | $41.90M derived: sum of 2 quarters · filed 2026-05-07 | $41.90M derived: sum of 3 quarters · filed 2026-05-07 | |
| 2025-12-31 | $3.90M derived: 10-Q 12 month − 10-Q 9 month · filed 2026-05-07 | $3.90M derived: sum of 2 quarters · filed 2026-05-07 | $78.80M 10-Q · filed 2026-05-07 | |
| 2025-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $74.90M 10-Q · filed 2025-11-05 | ||
| 2025-06-30 | $74.90M 10-Q · filed 2025-08-06 | |||
| 2024-12-31 | $21.80M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $22.70M derived: sum of 2 quarters · filed 2026-02-27 | $1.37B derived: sum of 3 quarters · filed 2026-02-27 | $1.65B 10-K · filed 2026-02-27 |
| 2024-09-30 | $900.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | $1.35B derived: sum of 2 quarters · filed 2024-11-07 | $1.63B 10-Q · filed 2024-11-07 | |
| 2024-06-30 | $1.34B derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-09 | $1.63B 10-Q · filed 2024-08-09 | ||
| 2024-03-31 | $281.60M 10-Q · filed 2024-05-10 | |||
| 2023-12-31 | $242.60M 10-K · filed 2025-03-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Avantor, Inc. (AVTR) | United States | $10.501B | -9.72 |
| REVVITY, INC. (RVTY) | United States | $16.814B | 53.44 |
| Alamar Biosciences, Inc. (ALMR) | United States | $2.300B | |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |